Skip to content
ppharmaranks
Menu

Tremelimumab-Actl: uses, dosing, side effects & brands

Tremelimumab-Actl is a medicine sold in the U.S. under one brand. Below: what the FDA label says, every product that contains it, what the pills look like, and its recall record.

By the pharmaranks editorial teamReviewed against the FDA (openFDA label, NDC Directory & Enforcement) sourcesUpdated Jul 24, 2026How we research

Key facts

Available as
Injectable
Sold as
Imjudo
Prescription?
Prescription only
Generic available?
Not in our catalog

Every tremelimumab-actl product we track (1)

Same active ingredient — different manufacturer, form, price and FDA recall record. That last one is what our independent score measures.

Only one: Imjudo.

What people report to the FDA about tremelimumab-actl

The FDA Adverse Event Reporting System (FAERS) collects reports from patients and clinicians. It holds 1 reports naming tremelimumab-actl, and the FDA flagged 100% of those reports as serious. The effects reported most often — leaving out reports about overdose, misuse or the condition being treated, which dominate the raw list for common medicines:

  • angina pectoris1 reports
  • cough1 reports
  • drug-induced liver injury1 reports
  • international normalised ratio increased1 reports

Read these as a signal, not a rate. A report does not mean tremelimumab-actl caused the effect — anyone can file one, and many describe people taking several medicines for several conditions. Crucially there is no denominator: FAERS does not record how many people took the drug, so these counts cannot be turned into “X% of patients” — a bigger number often just means a more widely used or more talked-about drug. Duplicates exist, and publicity drives reporting. For what is actually established, read the FDA label section above.

Source: openFDA drug/event (FAERS), retrieved July 26, 2026.

Related calculators

Frequently asked questions

Can you take tremelimumab-actl with other medicines?

It depends on the medicine. We check it against the FDA labels rather than guessing: our interaction checker searches each drug's own label for the other and quotes what it says, naming the section it came from. Run tremelimumab-actl against whatever else you take — and remember that a label not naming a drug is not the same as that combination being safe.

What forms does tremelimumab-actl come in?

Across the brands we track, tremelimumab-actl is currently marketed as injectable, per the FDA's National Drug Code Directory. Each form is dosed differently — follow the label for the exact product you were prescribed.

Is there a generic tremelimumab-actl?

We do not currently list a generic-labelled tremelimumab-actl product. That does not always mean none exists — it means none appears under a generic name in the FDA data we track. Ask your pharmacist.

Cite this page
APA
pharmaranks. (2026, July 24). Tremelimumab-Actl: uses, dosing, side effects & brands. https://pharmaranks.com/drugs/tremelimumab-actl
MLA
“Tremelimumab-Actl: uses, dosing, side effects & brands.” pharmaranks, 24 July 2026, https://pharmaranks.com/drugs/tremelimumab-actl.

We summarise public FDA and NIH sources — for a clinical claim, cite the primary source we link to as well.

Sources: FDA openFDA drug label, National Drug Code Directory, and Enforcement (recall) database. This page reproduces public FDA data and is not medical advice. Dosing is set by your prescriber.

Read the full FDA label for tremelimumab-actl on DailyMed (NIH) ↗.